Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hay

Showing results (241-250 of 652) with videos related to

Pageof 66
Sort By:
Current Opinion in Neurology|June 8, 2022
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?Betel Tesfay, William Kristian Karlsson, Rogelio Dominguez Moreno, et al.
British Journal of Pharmacology|January 18, 2006
Differential activation of G-proteins by mu-opioid receptor agonistsZuzana Saidak, Katherine Blake-Palmer, Debbie L Hay, et al.
American Journal of Public Health|April 17, 2020
Indoor Tanning Trends Among US Adults, 2007-2018Jennifer M Bowers, Alan C Geller, Elizabeth Schofield, et al.
Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
Molecular Pharmacology|February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexesDebbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Psycho-Oncology|February 9, 2016
Assessing real-time sun protection decisions using audio diaries: feasibility and outcomesLaura Fitzpatrick, Joshua Pulinat, Elyse Shuk, et al.
Journal of Health Psychology|August 17, 2017
Measurement invariance of intuitive cancer risk perceptions across diverse populations: The Cognitive Causation and Negative Affect in Risk scalesRaymond E Baser, Yuelin Li, Debra Brennessel, et al.
British Journal of Clinical Pharmacology|May 21, 2016
A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain modelsGuido van Amerongen, Matthijs W de Boer, Geert Jan Groeneveld, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.
Pageof 66

Showing results (241-250 of 652) with videos related to

Sort By:
Pageof 66
Current Opinion in Neurology|June 8, 2022
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?Betel Tesfay, William Kristian Karlsson, Rogelio Dominguez Moreno, et al.
British Journal of Pharmacology|January 18, 2006
Differential activation of G-proteins by mu-opioid receptor agonistsZuzana Saidak, Katherine Blake-Palmer, Debbie L Hay, et al.
American Journal of Public Health|April 17, 2020
Indoor Tanning Trends Among US Adults, 2007-2018Jennifer M Bowers, Alan C Geller, Elizabeth Schofield, et al.
Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.
Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.
Molecular Pharmacology|February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexesDebbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Psycho-Oncology|February 9, 2016
Assessing real-time sun protection decisions using audio diaries: feasibility and outcomesLaura Fitzpatrick, Joshua Pulinat, Elyse Shuk, et al.
Journal of Health Psychology|August 17, 2017
Measurement invariance of intuitive cancer risk perceptions across diverse populations: The Cognitive Causation and Negative Affect in Risk scalesRaymond E Baser, Yuelin Li, Debra Brennessel, et al.
British Journal of Clinical Pharmacology|May 21, 2016
A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain modelsGuido van Amerongen, Matthijs W de Boer, Geert Jan Groeneveld, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.
Pageof 66